A 67-year-old man with prostate cancer developed acute liver injury after robot-assisted radical prostatectomy. The cause was an unknown narrowing of the celiac trunk, leading to reduced blood flow. He fully recovered with supportive care.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Case Report
A 67-year-old man with prostate cancer developed acute liver injury after robot-assisted radical prostatectomy. The cause was an unknown narrowing of the celiac trunk, leading to reduced blood flow. He fully recovered with supportive care.
Ischemic acute liver injury is a rare, potentially life-threatening complication after major urological surgery, particularly in patients with advanced prostate cancer on neoadjuvant systemic therapy. This report describes a 67-year-old male with oligometastatic prostate cancer (cT3b cN1 M1b, initial prostate-specific antigen (PSA) 105 ng/mL) who received 6 months of neoadjuvant androgen deprivation therapy (ADT) combined with apalutamide. Due to persistent severe lower urinary tract symptoms, patient preference, and a very good response to hormonal therapy (preoperative PSA 0.6 ng/mL), robot-assisted radical prostatectomy with extended pelvic lymphadenectomy was performed uneventfully. On postoperative day 1, routine blood tests revealed elevated transaminases consistent with ischemic acute liver injury. The patient remained hemodynamically stable without jaundice or encephalopathy. Abdominal imaging demonstrated reduced contrast enhancement in the left hepatic lobe due to severe celiac trunk stenosis. Infectious, autoimmune, and primary drug-induced causes were not clinically suspected. Ischemic acute hepatic injury secondary to perioperative hypoperfusion superimposed on preexisting celiac trunk stenosis was diagnosed. Management involved intensive care monitoring, intravenous fluid resuscitation, temporary discontinuation of potentially hepatotoxic medications, and multidisciplinary consultation with a specialized liver center. No revascularization or other invasive interventions were required. Liver function improved partially by day 7 and normalized at long-term follow-up. At the 4-year follow-up, PSA remained undetectable (0.03 ng/mL) under ongoing dual hormonal therapy, with no evidence of biochemical or radiographic recurrence. This case illustrates the importance of perioperative liver monitoring in at-risk patients, the transient nature of mild ischemic acute liver injury with prompt supportive care, and the viability of multimodal treatment, including surgery for selected oligometastatic prostate cancer cases.
The goal of this case report is to present ischemic acute liver injury (also known as ischemic hepatitis or shock liver) as an uncommon but serious perioperative complication following robot-assisted radical prostatectomy (RARP) in a patient with oligometastatic prostate cancer receiving neoadjuvant therapy, highlighting its diagnosis, conservative management, rapid recovery, and preserved oncologic outcome1,2,3.
Oligometastatic prostate cancer is increasingly managed with multimodal approaches, including neoadjuvant androgen deprivation therapy (ADT) combined with novel hormonal agents such as apalutamide, followed by local therapy to improve progression-free survival3,4. However, such regimens, combined with comorbidities, polypharmacy, and surgical factors (e.g., pneumoperitoneum, steep Trendelenburg positioning), may heighten risks of systemic complications, including hepatic hypoperfusion5.
Ischemic acute liver injury arises from an acute reduction in hepatic blood flow, typically without frank shock, leading to centrilobular necrosis, marked aminotransferase elevations (often >10x upper limit of normal, peaking within 1–3 days), and rapid resolution upon reperfusion if the insult is transient6,7. It differs from drug-induced liver injury (prolonged exposure, cholestatic pattern) or viral hepatitis and is linked to low-flow states, vascular stenoses (e.g., celiac axis), or perioperative factors6. Reports of ischemic acute liver injury after urological procedures are sparse, with isolated cases tied to laparoscopic retraction or positioning, but none specifically describe post-RARP ischemic liver injury in the context of celiac trunk stenosis.
RARP offers advantages over open prostatectomy, including reduced blood loss, shorter hospitalization, and equivalent oncologic outcomes, but its prolonged pneumoperitoneum and extreme positioning can compromise splanchnic perfusion in predisposed patients (e.g., those with vascular stenoses or atherosclerosis)5.
The significance of this case lies in addressing an underreported scenario in the literature: perioperative ischemic hepatic injury in advanced prostate cancer patients on neoadjuvant therapy undergoing RARP, demonstrating early detection via routine labs and imaging, and successful multidisciplinary management.
Case Presentation
A 67-year-old male was diagnosed with prostate cancer in December 2021 (initial PSA 105 ng/mL, 11/12 biopsy cores positive, Gleason 3+4=7 with cribriform pattern, ISUP grade group 2). A thoracoabdominal computer tomography (CT) scan showed right inguinal lymph node metastasis and osteoblastic lesion in the right ilium. The right ilium bone lesion was also confirmed via skeletal scintigraphy. A pelvic magnetic resonance imaging (MRI) showed a locally advanced cancer extending beyond the prostate in the periprostatic tissue with suspected infiltration of both seminal vesicles (cT3b cN1 M1b). Comorbidities included hypertension, peripheral arterial disease, retinal detachment, and prior cataract surgery. Medications included acetylsalicylic acid, ramipril, amlodipine, simvastatin, and allopurinol. The patient had no significant residual urine and a prostate volume of 43 mL on transrectal ultrasound (TRUS), with intravesical prostate protrusion (IPP) grade I; International Prostate Symptom Score (IPSS) was 20 with a quality-of-life score of 3; International Index of Erectile Function (IIEF-5) score was 1/25.
Neoadjuvant ADT plus apalutamide 60 mg daily was administered for 6 months. Before initiating apalutamide and during therapy, liver function evaluation was normal, without any pathology. The CT scan 6 months after hormonal therapy began showed a reduction in lymph node size (from 1.5 cm to 0.5 cm) and a stable solitary bone metastasis. Prostate MRI showed a reduction in tumor size and prostate volume (23 mL). A very good biochemical response (preoperative PSA 0.6 ng/ml) was also achieved. Persistent severe lower urinary tract symptoms prompted the patient's preference for surgical management over radiotherapy. The preoperative laboratory workup, including transaminase levels, was within the normal range. Robot-assisted radical prostatectomy with extended pelvic lymphadenectomy was performed in August 2022, without intraoperative complications. Final pathology: ypT3b pN1 (15/19 positive nodes) M1b L1 Pn1 R0, minimal treatment effect (Helpap score 8)8. The console time was 120 min, the total surgical time was 135 min with minimal intraoperative blood loss (less than 100 mL).
On postoperative day 1, routine laboratory evaluation revealed elevated transaminases suggestive of diffuse liver injury. The patient was hemodynamically stable with no jaundice, encephalopathy, or abdominal pain. Abdominal ultrasound indicated features of acute hepatitis; contrast-enhanced CT showed reduced enhancement in the left hepatic lobe and severe celiac trunk stenosis.
Diagnosis, Assessment, and Plan
Initial evaluation included serial liver function tests and exclusion of congestive hepatopathy (no biliary dilatation or congestion on imaging). Differential diagnoses encompassed drug-induced liver injury from apalutamide or simvastatin and ischemic hepatitis. Infectious and autoimmune hepatitis were ruled out due to the absence of medical history or clinical signs.
The pattern of rapid aminotransferase rise, imaging evidence of celiac trunk stenosis with asymmetric left lobe hypoenhancement, and absence of alternative causes supported ischemic acute hepatic injury due to perioperative hypoperfusion (pneumoperitoneum, positioning, possible transient hypotension) on a background of preexisting vascular stenosis.
The plan included immediate ICU admission for close monitoring, intravenous fluid resuscitation to optimize perfusion, temporary discontinuation of potentially hepatotoxic medications (apalutamide held, simvastatin stopped), supportive care, and urgent multidisciplinary consultation with an academic liver center. No endovascular or surgical intervention for the stenosis was pursued after radiology and vascular surgery review, as the stenosis was non-occlusive and presumed to have adequate collaterals.
Access restricted. Please log in or start a trial to view this content.
The patient consented in writing to all treatment steps and anonymous publication. The study complies with the Declaration of Helsinki and was approved by the ethics committees of the Westfalen-Lippe Medical Association and the University of Muenster (2023–500-f-S) for retrospective data management.
1. Preoperative preparation
2. Patient positioning and robot docking
3. Robot-assisted radical prostatectomy with extended pelvic lymphadenectomy
4. Postoperative management and monitoring
Access restricted. Please log in or start a trial to view this content.
The procedure went without any complications. The console duration was 120 min; the whole operating time was 135 min, with minimal blood loss (<100 mL). Postoperatively and during routine controls on the first postoperative day, including abdominal sonography and laboratory workup, elevated transaminase levels were observed (Table 1). The case was therefore discussed with anesthesiologists, and the patient was transferred to the intensive care unit. Following consultation with the hepatology team, a h...
Access restricted. Please log in or start a trial to view this content.
Ischemic acute hepatic injury remains exceptionally rare following robot-assisted radical prostatectomy, with literature primarily describing retraction-related ischemia in laparoscopic urology or positioning effects, but no prior reports linking celiac trunk stenosis to this complication post-RARP 9. While spontaneous symptomatic celiac artery dissections are rare10, stenosis is more common11. In this patient, preexisting undiagnosed celiac stenosis...
Access restricted. Please log in or start a trial to view this content.
The authors used a language model (Gemini) exclusively for language polishing and grammatical refinement. All scientific content was controlled, verified, and approved by the authors, who assume full responsibility for the final manuscript.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| 12-mm assistant trocar | Applied medical | CFF73 Kii system | Right lower abdomen quadrant |
| 5-mm assistant trocar | Applied medical | CFI05 Kii system | Right upper abdomen quadrant |
| 8-mm robotic trocar | Intuitive Surgical | 470179 | Ports for robotic instruments |
| Apalutamide | Janssen-Cilag | 59676-600-12 | 60 mg tablet, oral daily |
| Barbed suture (4-0) | Ethicon J&J | VLOCL | For dorsal vascular complex ligation |
| Bipolar forceps | Intuitive Surgical | 471172 | Robotic instrument |
| Double-armed barbed suture (3-0) | Ethicon J&J | VLOCM | For vesicourethral anastomosis |
| Grasping retractor | Intuitive Surgical | 471344 | Robotic instrument |
| Monopolar scissors | Intuitive Surgical | 470184 | Robotic instrument |
| Needle holder | Intuitive Surgical | 420048 | Robotic instrument |
| Robotic system | Intuitive Surgical | X system | da Vinci Surgical System |
| Endoscope / Camera | Intuitive Surgical | 470027 | 30° da Vinci endoscope |
| Hem-o-lok clips | Teleflex | 544230 | Medium-large polymer clips for vascular control |
| Prolene suture (3-0) | Ethicon J&J | VCP333H | For bladder neck reconstruction |
| Laparoscopic suction irrigator | Applied Medical | C6001 | For aspiration and irrigation |
| Foley catheter | Well Lead Medical | 0165V18 | 18 Fr. 2 way |
| Surgical drapes | Microtek Medical | Ecolab RCD-100 | Sterile procedure drapes |
Access restricted. Please log in or start a trial to view this content.
This article has been published
Video Coming Soon